Leading Pharmaceutical Companies R&D Expenditures and Major Programs
| Publication Date | September 2009 |
|---|---|
| Publisher | Venture Planning Grp. |
| Product Type | Report |
| Pages | 160 |
| ISBN Number | not applicable |
| Product Code | VEP00265 |
Buy this product or for assistance call +44 20 7060 7474
Summary
For each company, the report provides:
- Annual R&D budget.
- Research facilities and staff.
- New technologies, drugs, and indications in development, including their phase and anticipated introduction dates.
Content
- Companies Mentioned
- AstraZeneca
- Bristol-Myers Squibb
- GlaxoSmithKline
- Johnson & Johnson
- Merck
- Novartis
- Pfizer
- Roche
- Sanofi-Aventis
- Wyeth
Delivery Details
PDF:Delivered by email usually within 12 to 24 UK business hours.
Related Products
Industry Events
Innovations in Oncology Drug Discovery, Development & Delivery
01 Dec 09 to 01 Dec 09
N/A, UK
view summary >>
Best Practice in Phase IV Clinical & Observational Research
03 Dec 09 to 04 Dec 09
Prague, Czech Republic
view summary >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharma Chemicals
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer? 
Advertising/Affiliates
View Our Publishers
News
About Us
Meet Us
Jobs
Contact Us
Categories and Subcategories
